F18.221 Inhalant dependence with intoxication delirium

Name of the Condition

• Common Name: Inhalant Dependence with Intoxication Delirium
• Medical Term: Inhalant Dependence with Intoxication Delirium

Summary

Inhalant dependence with intoxication delirium is a substance use disorder characterized by a problematic pattern of inhalant use leading to clinically significant impairment or distress, with current intoxication and delirium. It involves a combination of physiological, behavioral, and cognitive symptoms related to continued use despite adverse consequences, including tolerance, withdrawal, and compulsive use, while also presenting acute intoxication effects and delirium. This condition impacts physical health, mental functioning, and daily life.

Causes

Inhalant dependence with intoxication delirium develops from repeated misuse of inhalants—substances that produce chemical vapors—for their psychoactive effects. Inhalants are often common household or industrial products, such as glue, paint thinners, aerosols, or solvents. Prolonged use can alter brain chemistry, leading to dependence and related health issues, with intoxication and delirium occurring during active use.

Risk Factors

• Adolescents and young adults are more likely to experiment with inhalants.
• Individuals with a history of substance abuse or mental health disorders.
• Accessibility to inhalant products.
• Lack of proper supervision or guidance.

Symptoms

• Intense cravings or compulsive inhalant use.
• Coordination problems, dizziness, or lethargy.
• Unexplained behavioral changes such as aggression or mood swings.
• Cognitive impairment or memory issues.
• Withdrawal symptoms when use is reduced or stopped.
• Acute intoxication effects, including impaired judgment or perception.
• Delirium, characterized by confusion, disorientation, or altered consciousness.

Diagnosis

Diagnosis involves a comprehensive evaluation of the patient's history, including patterns of inhalant use, and clinical assessment of symptoms. Healthcare providers may use standardized criteria to determine the presence of dependence, intoxication, and delirium. Physical exams and laboratory tests may help rule out other conditions or identify related complications. Documentation should reflect the co-occurrence of dependence, intoxication, and delirium.

Treatment Options

Treatment typically includes medical stabilization to address acute symptoms, such as delirium or intoxication, followed by behavioral therapies and support programs. Medications may be used to manage withdrawal or co-occurring conditions. Long-term care often involves counseling, support groups, and monitoring for relapse. Individualized plans are tailored to the patient's needs.

Prognosis and Follow-Up

Prognosis depends on the severity of dependence, the presence of delirium, and the patient's response to treatment. Early intervention and consistent follow-up improve outcomes. Regular monitoring for relapse, mental health changes, and physical complications is essential. Long-term recovery may require ongoing support and adjustments to treatment plans.

Complications

• Severe cognitive impairment or permanent brain damage.
• Respiratory failure or other organ damage from chronic inhalant use.
• Increased risk of accidents or injuries due to impaired judgment.
• Worsening of mental health conditions, such as depression or anxiety.
• Social or occupational dysfunction.

Lifestyle & Prevention

• Avoiding inhalant use and educating others about its risks.
• Seeking help for substance use concerns early.
• Engaging in healthy coping mechanisms and stress management.
• Building a support network of family, friends, or professionals.
• Participating in community or school-based prevention programs.

When to Seek Professional Help

Seek immediate medical attention if experiencing severe confusion, disorientation, or altered consciousness. Contact a healthcare provider for persistent inhalant use, withdrawal symptoms, or concerns about dependence. Early intervention can prevent complications and improve outcomes.

Tips for Medical Coders

Document the presence of inhalant dependence, current intoxication, and delirium to support the use of F18.221. Ensure clinical notes clearly describe the relationship between these elements, including the timing and severity of symptoms. Verify that the diagnosis aligns with standardized criteria for substance use disorders and delirium.